Loading patent…
AssigneesCambridge NeuroScience, Inc., Ludwig Institute for Cancer Research
InventorsAndrew Goodearl, Paul Stroobant, Luisa Minghetti, Michael Waterfield, Mark Marchioni, Mario Su Chen, Ian Hiles
Estimating the term…
Disclosed is the characterization and purification of DNA encoding a numerous polypeptides useful for the stimulation of glial cell (particularly, Schwann cell) mitogenesis and treating glial cell tumors. Also disclosed are DNA sequences encoding novel polypeptides which may have use in stimulating glial cell mitogenesis and treating glial cell tumors. Methods for the synthesis, purification and testing of both known and novel polypeptides for their use as both therapeutic and diagnostic aids in the treatment of diseases involving glial cells are also provided. Methods are also provided for the use of these polypeptides for the preparation of antibody probes useful for both diagnostic and therapeutic use in diseases involving glial cells.
A composition comprising a recombinant polypeptide, said polypeptide comprising an epidermal growth factor-like domain, said polypeptide having an amino acid sequence which is identical to that of a naturally occurring polypeptide encoded by a human GGF/p185 erb B2 ligand gene, wherein said polypeptide is not Neu differentiation factor (NDF), Heregulin-.alpha., Heregulin-.beta.1, Heregulin-.beta.2 or Heregulin-.beta.03.
Dependencies are inferred from the claim text.